Macular Hole Progression following Ocriplasmin Intravitreal Injection

Ocriplasmin is a protease which has been approved for the treatment of symptomatic vitreomacular adhesion (VMA). A 63-year-old presented with blurred vision in the left eye and a best corrected visual acuity of 6/18. Optical coherence tomography revealed VMA with an underlying macular hole and she s...

Descripción completa

Detalles Bibliográficos
Autores principales: Casswell, Edward, Fernandez-Sanz, Guillermo, Mitry, Danny, Luk, Sheila, Zakir, Rahila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279821/
https://www.ncbi.nlm.nih.gov/pubmed/25580329
http://dx.doi.org/10.1155/2014/403461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279821/
https://www.ncbi.nlm.nih.gov/pubmed/25580329
http://dx.doi.org/10.1155/2014/403461

Ejemplares similares